Increasing Strep Throat Transmission Fueling Growth In The Pharyngitis Treatment Market Driver: A Major Catalyst in the Evolution of the Pharyngitis Treatment Market in 2025

What industry-specific factors are fueling the growth of the pharyngitis treatment market?
The escalating incidence of strep throat is predicted to fuel the expansion of the pharyngitis treatment market. Strep throat, which mainly affects the throat and tonsils, is an infectious bacterial disease. Rapid and effective strep throat treatment with antibiotics can ease the symptoms, prevent any potential complications and minimize the chances of transferring the infection to other people. For instance, as per the U.S. based government agency, the Centers for Disease Control and Prevention, there are roughly 14,000 to 25,000 invasive group A strep diseases that transpire in the U.S. every year, as of June 2022. Moreover, strep diseases prompt approximately 5.2 million outpatient visits and correspond to 2.8 million prescriptions for antibiotics annually. Therefore, the escalating incidence of strep throat propels the pharyngitis treatment market. Pharyngitis Treatment Market Driver: Rising Occurrence Of Influenza Stirs Pharyngitis Treatment Market

Get Your Pharyngitis Treatment Market Report Here:
https://www.thebusinessresearchcompany.com/report/pharyngitis-treatment-global-market-report

What Is the projected market size and growth rate for the pharyngitis treatment market?
Over the years, the market size for the treatment of pharyngitis has consistently expanded. A surge from $2.27 billion in 2024 to $2.37 billion in 2025 is anticipated, with a compound annual growth rate (CAGR) of 4.5%. The expansion during this historical period can be linked to the widespread and rising occurrence of flu, the growing prevalence of pharyngitis, a higher awareness towards this condition, improved healthcare access and an increase in disposable incomes.

In the coming years, the market for pharyngitis treatment is projected to experience significant expansion. By 2029, it is estimated to reach $2.99 billion, with a compound annual growth rate (CAGR) of 6.0%. Factors contributing to this growth within the forecast period can be ascribed to the use of rapid point-of-care tests, the demand for personalised medicine, the increasing incidence of antibiotic resistance, and the growing emphasis on hand hygiene. Major trends during the forecast timeframe include advancements in the research and development of treatments for pharyngitis, digital health technologies, and the integration of telehealth.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12937&type=smp

What new trends are reshaping the pharyngitis treatment market and its opportunities?
Leading businesses in the pharyngitis treatment market are concentrating on the creation of novel products such as oral monotherapy in order to improve patient compliance and offer effective, accessible treatment alternatives. The term oral monotherapy denotes the utilization of a singular drug or medication, taken orally, to counter a specific illness or condition. This treatment approach only involves a single therapeutic agent, contrasting with multiple treatment concoctions, to achieve the necessary therapeutic impact. For example, Novartis AG, a pharmaceutical corporation based in Switzerland, received FDA approval in December 2023 for Fabhalta (iptacopan), marking its establishment as the inaugural oral monotherapy for adult patients with paroxysmal nocturnal hemoglobinuria (PNH). This significant progress, achieved on [date], presents a fresh therapeutic choice that augments hemoglobin levels, thus negating the requirement for blood transfusions.

What major market segments define the scope and growth of the pharyngitis treatment market?
The pharyngitis treatment market covered in this report is segmented -

1) By Drug Class: Beta Lactams, Macrolides, Cephalosporins, Fluoroquinolones, Tetracycline, Other Drug Classes
2) By Source of Infection: Viral, Bacterial
3) By Modes Of Delivery: Oral, Intravenous, Intramuscular, Other Modes Of Delivery
4) By End-Users: Hospitals, Homecare, Specialty Centers, Other End-Users

Subsegments:
1) By Beta Lactams: Penicillins, Amoxicillin, Ampicillin
2) By Macrolides: Erythromycin, Azithromycin, Clarithromycin
3) By Cephalosporins: Cefuroxime, Ceftriaxone, Cefdinir
4) By Fluoroquinolones: Ciprofloxacin, Levofloxacin, Moxifloxacin
5) By Tetracycline: Doxycycline, Minocycline, Tetracycline
6) By Other Drug Classes: Clindamycin, Sulfonamides, Carbapenems

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12937

Which region dominates the pharyngitis treatment market?
North America was the largest region in the pharyngitis treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in pharyngitis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Which key market leaders are driving the pharyngitis treatment industry growth?
Major companies operating in the pharyngitis treatment market are Pfizer Inc., GlaxoSmithKline PLC, Genentech Inc., Pliva Hrvatska D.o.o., Viatris Inc., Teva Pharmaceutical Industries Ltd., AbbVie Inc., Medtronic PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Ltd., Fresenius Kabi AG, Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Cipla Limited, Hikma Pharmaceuticals PLC, Lupin Limited, Pliva Hrvatska D.o.o., LivaNova PLC, Genentech Inc.

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=12937&type=smp

What Is Covered In The Pharyngitis Treatment Global Market Report?

•Market Size Forecast: Examine the pharyngitis treatment market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the pharyngitis treatment market for a structured understanding.
•Key Players Overview: Analyze major players in the pharyngitis treatment market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the pharyngitis treatment market.
•Segment Contributions: Evaluate how different segments drive overall growth in the pharyngitis treatment market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the pharyngitis treatment market.
•Industry Challenges: Identify potential risks and obstacles affecting the pharyngitis treatment market.
•Competitive Landscape: Review strategic developments in the pharyngitis treatment market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.